Viemed Healthcare (VMD) EBITDA Margin Growth (1y) (2019 - 2026)
Viemed Healthcare (VMD) EBITDA Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 146.00 |
| 10 | Viemed Healthcare | 330.06 Mn | 319.38 Mn | 45.05 Mn | -237.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -237.00 |
| Mar 31, 2026 | -80.00 |
| Dec 31, 2025 | 36.00 |
| Sep 30, 2025 | -186.00 |
| Jun 30, 2025 | 150.00 |
| Mar 31, 2025 | 214.00 |
| Dec 31, 2024 | 21.00 |
| Sep 30, 2024 | 34.00 |
| Jun 30, 2024 | -81.00 |
| Mar 31, 2024 | -114.00 |
| Dec 31, 2023 | 36.00 |
| Sep 30, 2023 | 444.00 |
| Jun 30, 2023 | 365.00 |
| Mar 31, 2023 | -221.00 |
| Dec 31, 2022 | -526.00 |
| Sep 30, 2022 | -577.00 |
| Jun 30, 2022 | -674.00 |
| Mar 31, 2022 | 231.00 |
| Dec 31, 2021 | -221.00 |
| Sep 30, 2021 | -199.00 |